Resultados de la búsqueda 611-620 of 2910 for Cecum

  1. Oncología (médica) - Ensayos clínicos

    Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to determine the prevalence of genetic mutations in cancer patients from various ...

  2. Cáncer de colon - Médicos y departamentos - Mayo Clinic

    Infórmate más sobre los síntomas y las causas de este tipo de cáncer que comienza en el intestino grueso. Infórmate sobre las opciones de tratamiento, ...

  3. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to compare the effects, good and/or bad of two treatment methods on subjects and their cancer. Proton beam radiation therapy is one ...

  4. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to, in tissue, discover and validate DNA methylation markers (MDMs) for detection of invasive urothelial carcinoma ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. 99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates ...

  6. Neurocirugía - Ensayos clínicos

    Rochester, Minn., Scottsdale/Phoenix, Ariz. This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

  8. Oncología (médica) - Ensayos clínicos

    Jacksonville, Fla. The purpose of this study is to compare the effects on low-risk breast cancer receiving usual care that includes regional radiation therapy, ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the safety and tolerability of personalized neoantigen peptide administered in combination with pembrolizumab to ...

  10. Oncología (médica) - Ensayos clínicos

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...